Mr. Rav Mlait reports

CANNABIX TECHNOLOGIES RECEIVES NOTICE OF ALLOWANCE FROM USPTO FOR CONTACTLESS BREATH ANALYSIS

The U.S. Patent and Trademark Office has issued a notice of allowance for patent application No. 18/1729,658 entitled, "Contact-Free Breath Analysis Device and Method" to Cannabix Technologies Inc.

This patent application is centred on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology. The technology has wide-ranging utility, can be integrated into everyday environments such as vehicles, workplaces or public kiosks, and supports fast, reliable testing without requiring physical contact. The technology can be used in unmanned breath devices, offering real-time feedback through visual indicators and displays, and is well suited for applications in law enforcement, workplace safety and public health monitoring. The system intelligently adjusts its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis.

This patent application further augments Cannabix's leadership position at the forefront of breath sampling and detection techniques, and continues to expand the intellectual capital of Cannabix's breath capture and analytic portfolio. It should be noted that a notice of allowance from the USPTO does not constitute a grant of patent. The company will report on future material developments regarding its "Contact-Free Breath Analysis Device and Method" patent application in due course.

About Cannabix Technologies Inc.

Cannabix is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. Breath testing for Delta-9 tetrahydrocannabinol (the primary psychoactive ingredient in cannabis) focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations which strive to improve alcohol safety and monitoring.

We seek Safe Harbor.